000 05013nam a2200397 i 4500
003 ESmaUEC
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
040 _aES-MaUEC
_bspa
_cES-MaUEC
336 _aTexto
_btxt
_2rdacontent
710 2 _aSpringerLink (Online service)
_9106996
999 _c109306
_d109306
_x1
001 109306
005 20230214040201.0
008 190311s2019 gw | o |||| 0|eng d
020 _a9783030061159
024 7 _a10.1007/978-3-030-06115-9
_2doi
050 4 _aRS201.N35
_b2019 EB
245 0 0 _aSurface Modification of Nanoparticles for Targeted Drug Delivery
_cedited by Yashwant V Pathak.
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (XVIII, 499 páginas)
_b142 ilustraciones, 110 ilustraciones a color
337 _aelectrónico
_bc
338 _arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aUnderstanding the Surface Characteristics of Nanoparticles -- Surface Modification of Nanoparticles for Targeted Drug Delivery -- Surface-Modified PLGA Nanoparticles for Targeted Drug Delivery to Neurons -- Nanoparticles for Site Specific Drug Delivery -- Stealth Properties of Nanoparticles against Cancer: Surface Modification of NPs for Passive Targeting to Human Cancer Tissue in Zebra Fish -- Passive targeting of nanoparticles to cancer -- Surface Modification of Magnetic Nanoparticles in Biomedicine -- A novel strategy for the surface modification of super paramagnetic (Fe3O4) iron oxide nanoparticle for lung cancer imaging -- Biodegradable nanoparticles for drug delivery and targeting -- Functionalized antibacterial nanoparticles in controlling biofilm and intracellular infections -- Surface modifications of liposomes for drug targeting -- Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system -- Surface Modification of Metallic Nano particles -- Successful Delivery of Zidovudine-loaded Docosanol Nanostructured Lipid Carriers (Docosanol NLCs) into rat brain -- Brain targeted drug delivery with surface modified nanoparticles -- Surface Modification of Resorcinarene Based Self-Assembled Solid Lipid Nanoparticles for Drug Targeting -- Targeted delivery of surface modified nanoparticles:Modulation of inflammation for acute lung injury -- Surface modification of Nano carriers for specific cell targeting for better therapeutic effect -- Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers -- Surface modification of Nano carriers for specific cell targeting for better therapeutic effect -- Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers -- Surface Modification of Gold Nanoparticles for Targeted Drug Delivery -- Surface modification and bioconjugation of nanoparticles for MRI technology -- Surface Modified Lanthanide Nanomaterials for Drug Delivery -- Engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers -- Application of Nanoparticles in treating Periodontitis: Preclinical and Clinical overview -- Surface Modification of Nanoparticles for Ocular Drug Delivery.
520 3 _aThis unique book discusses various new techniques developed to enhance the application of nanoparticulate drug delivery systems using surface modification of nanoparticles. The understanding of the surface characteristics of nanoparticles is growing significantly with the advent of new analytical techniques. Polymer chemistry is contributing to the development of many new versatile polymers which have abilities to accommodate many different, very reactive chemical groups, and can be used as a diagnostic tool, for better targeting, for more effective therapeutic results as well as for reducing the toxic and side effects of the drugs. Surface modification of such polymeric nanoparticles has been found by many scientists to enhance the application of nano-particles and also allows the nanoparticles to carry specific drug molecule and disease /tumor specific antibodies which refine and improve drug delivery. Surface Modification of Nanoparticles for Targeted Drug Delivery is a collection of essential information on various applications of surface modification of nano-particles and their disease specific applications for therapeutic purposes.
988 _aPrimersemestre_2019_BiomedLife
650 7 _2embne
_aNanotecnología
_9158453
650 7 _2embne
_aSistemas de liberación de fármacos
_9667667
700 1 _aPathak, Yashwant V.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030061142
776 0 8 _iPrinted edition:
_z9783030061166
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-06115-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _aSI
_cm
_dz
_feng
_ggw
_h0
_b08/2019
_ek
_zSI